Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Mehta-Damani

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|August 8, 2024
IL-2 based cancer immunotherapies: an evolving paradigmSushama Rokade, Anita Mehta Damani, Martin Oft, et al.
Biotechnology and Bioengineering|July 23, 2005
An analysis of variability in the manufacturing of dexosomes: implications for development of an autologous therapySanjay Patel, Anita Mehta-Damani, Helen Shu, et al.
The AAPS Journal|August 14, 2021
The Evolution of Single-Cell Analysis and Utility in Drug DevelopmentShibani Mitra-Kaushik, Anita Mehta-Damani, Jennifer J Stewart, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptidesDi-Hwei Hsu, Pedro Paz, Gilbert Villaflor, et al.
Cell Reports|December 20, 2025
An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapyIevgen Koliesnik, Michael Totagrande, Bhargavi Jayaraman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|August 8, 2024
IL-2 based cancer immunotherapies: an evolving paradigmSushama Rokade, Anita Mehta Damani, Martin Oft, et al.
Biotechnology and Bioengineering|July 23, 2005
An analysis of variability in the manufacturing of dexosomes: implications for development of an autologous therapySanjay Patel, Anita Mehta-Damani, Helen Shu, et al.
The AAPS Journal|August 14, 2021
The Evolution of Single-Cell Analysis and Utility in Drug DevelopmentShibani Mitra-Kaushik, Anita Mehta-Damani, Jennifer J Stewart, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptidesDi-Hwei Hsu, Pedro Paz, Gilbert Villaflor, et al.
Cell Reports|December 20, 2025
An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapyIevgen Koliesnik, Michael Totagrande, Bhargavi Jayaraman, et al.
Pageof 1